News ArchivesRead News
New finding could help Parkinson's patients
Tuesday December 11, 2012
Swedish scientists may have discovered a way of stopping dyskinesia, or involuntary movements, in mid-to-late stage Parkinson's disease.
thelocal.se - In tests with laboratory animals, the Swedish scientists managed to stop the movements completely, having identified the area of the brain where the debilitating movements are activated as a side effect of the medication L-dopa.
Scientists told Sveriges Radio (SR) that the aim is now to develop new medication suitable for humans.
Such an achievement would essentially mean finding a cure for Parkinson's, or it would at least constitute a functioning treatment, according to Pär Halje, a neuroscience researcher at Lund University.
"We were very surprised, I have to admit," said Per Pettersson, a neurophysiology researcher at Lund University.
"We had not expected this at all, but since the phenomenon was so clear and was repeated in all lab animals in each test, we realized that we had discovered a new pathophysiological phenomenon."
The symptoms of Parkinson’s disease are caused by a breakdown of nerve cells that produce dopamine. This causes slow movement, tremors and stiffness, which can be controlled by medication, but the debilitating side effects kick in after around five years.
Up until now, scientists have believed that the involuntary movements are activated in a deep part of the brain, but the Lund University researchers have for the first time been able to demonstrate that it is the shallow parts of the brain that after several years of treatment become oversensitive to the Parkinson's disease medication.
With the help of advanced technology, they were able to track brain activity in rats with Parkinson's and could block the parts of the cerebral cortex that had become oversensitive to the medication.
In Sweden, around 20,000 people suffer from Parkinson's disease.
Recent NewsMay 24 - Survival Rates Differ Widely in Parkinson's, MSA, Lewy Bodies
May 22 - Discovery may offer hope to Parkinson's disease patients
May 15 - Study offers answers on life expectancy for people with Parkinson's disease, Lewy body dementia
May 5 - Parkinson's in a dish: Researchers reproduce brain oscillations
May 5 - ‘Hunger Hormone’ Could Help Treat Parkinson’s Disease
May 3 - Antibiotic doxycycline may offer hope for treatment of Parkinson's disease
May 1 - Impulse Control Disorders in Parkinson's Disease: Building Physician, Patient Awareness
Apr 28 - Does Parkinson’s disease begin in the gut?
Apr 28 - New empathy-creating digital device could be revolutionary for caregivers
Apr 24 - Treating Depression With Deep Brain Stimulation Works—Most of the Time
Apr 24 - Parkinson’s disease shows links to depression
Apr 21 - TOLEDO Trial: Apomorphine Infusions Reduce 'Off' Time in Parkinson's Disease
Apr 21 - New drug provides long-awaited breakthrough for Parkinson's psychosis
Apr 12 - Obstructive Sleep Apnea Affects Cognition in Parkinson's Disease
Apr 11 - Seattle boxing gym giving hope to Parkinson's patients
Apr 10 - A new rhythm
Apr 10 - Brain cells reprogrammed to make dopamine, with goal of Parkinson's therapy
Apr 6 - FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions
Apr 5 - Combatting the isolation of young onset Parkinson's disease
Apr 1 - The Kid is Alright